Recursion Pharma's AI-powered therapy reduces polyp growth in a rare disease trial

0
96
Recursion Pharma , which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths in the colon in patients with a rare genetic condition.

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here